HENDERSON, NV / ACCESSWIRE / March 21, 2019 / The electricity consumption of cannabis grow houses is staggering when compared to business and residential use. In 2015, the average electricity consumption of a 5,000-square-foot indoor facility in Boulder County was 41,808 kilowatt-hours per month, while an average household in the county used about 630 kilowatt-hours. A 2012 report on the carbon footprint of indoor production found that cannabis production makes up 1 percent of national electricity use, and in California, the top-producing state, that number rises to 3 percent.
An indoor facility can have lighting intensities similar to hospital operating rooms, which are 500 times greater than recommended reading light levels. These facilities can also have 30 hourly temperature or fan speed air changes, which is 60 times the rate in a normal home. Put another way, a four-plant lighting module uses as much electricity as 29 refrigerators.
Microgrids and microgrid software solutions can manage this kind of electricity usage and ultimately improve its efficiency.
In a recent press release, microgrid company CleanSpark, Inc. (CLSK) CEO S. Matthew Shultz stated, ''(The company) is currently focusing our marketing efforts on the largest users in the cannabis market, the agricultural (grow) facilities.'' He continued to say, ''opportunity in the cannabis market is unprecedented due to the high energy usage of these facilities in both the US and Canada. In many cases our solution is capable of virtually eliminating the demand charges that can account for almost 50% of the utility charges for such a facility.'' CLSK should have no problem landing cannabis clients - the company's custom power solution and mPulse software for cannabis producers cuts the monthly electricity bill of indoor grow-houses by up to 82%.
Today we are highlighting: CleanSpark, Inc. (CLSK), GW Pharmaceuticals plc (GWPH), Emerald Health Therapeutics (EMHTF), Canadian Solar, Inc. (CSIQ), and Seaspan Corporation (SSW).
CleanSpark, Inc. (CLSK) (Market Cap: $150.610M; Share Price: $3.62) recently updated its shareholders on several major initiatives.
Highlights from CLSK's latest update include:
- Closing a $5 million round of funding
- Engaging a firm to navigate the company's up listing
- Announced the near completion of a $900k contract to install a CLSK microgrid at a U.S. Marine Corps Base
- Continued progress on their $18.3 million deal with NYSE company MAC
- Closing of an acquisition adding $3.6 million in gross sales to CLSK's bottom line during early 2019 alone
GW Pharmaceuticals plc (GWPH) (Market Cap: $5.21B; Share Price: $170.40) is the developer of Epidiolex®, which is the first cannabis plant-derived medicine ever approved by the FDA and it has been rescheduled by the U.S. DEA to a schedule V. It announced that GW Research Ltd. has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $105,000,000. GW was awarded the voucher under a U.S. Food and Drug Administration (FDA) program intended to encourage the development of treatments for rare pediatric diseases. GW Research Ltd. received the PRV when EPIDIOLEX® (cannabidiol) was approved by the FDA for the treatment of seizures associated with Lennox-Gastaut Syndrome or Dravet syndrome, two rare, severe childhood-onset epilepsies. The transaction remains subject to customary closing conditions, including anti-trust review.
Emerald Health Therapeutics, Inc. (EMHTF) (Market Cap: $490.306M; Share Price: $3.28) announced the launch of Verdélite Sciences Inc., a wholly-owned, Québec-based production subsidiary licensed by Health Canada. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes.
Canadian Solar, Inc. (CSIQ) (Market Cap: $1.384B; Share Price: $23.62) announced that it will hold a conference call on Thursday, March 21, 2019 to discuss the company's fourth quarter and full year 2018 results and business outlook.
Canadian Solar has been witnessing flat demand for its modules from China for the past couple of quarters, thanks to this nation's latest solar policy. This, in turn, is pulling down the company's module shipment volumes and thereby affecting its performance. We can expect this trend to have continued in the to-be-reported quarter as well. However, Canadian Solar's consistent focus on reducing its cost of production is commendable. This should get duly reflected in the company's upcoming results.
A company recently announcing their year-end financial results, Seaspan Corporation (SSW) (Market Cap: $1.742B; Share Price: $8.09), reported earnings per diluted share of $0.25 for the fourth quarter and $1.31 for the full year, including record operating earnings of $134.4 million for the fourth quarter and $469.9 million for the full year 2018.
Priyanka Goel, CFA
This article was written by Regal Consulting, LLC (''Regal Consulting''). Regal Consulting has agreed to a three-month term consulting agreement with CLSK dated 9/12/18. The agreement calls for $10,000 in cash, and 30,000 restricted 144 shares of CLSK per month. Regal and CLSK have signed an amendment to extend the contract for twelve months starting 10/10/18, and increased the cash component to $20,000 per month. CLSK has paid an additional $12,000 for services provided in November. CLSK has paid an additional $88,000 for services provided in December. CLSK has paid an additional $100,000 for services for January. CLSK has paid an additional $80,000 for services for February. Regal was paid an additional $55,000 for March services and possibly compensated more for March services in the future, at which time Regal will update this disclaimer. All payments were made directly by Clean Spark, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. CLSK was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
Full Legal Disclaimer Click Here.
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Country: United States
SOURCE: ACR Communication LLC
View source version on accesswire.com: